vo feature drug therapy tardive dyskinesia

A U.S. federally funded clinical trial is testing whether the experimental antiviral drug remdesivir works better against COVID-19 if given with a powerful anti-inflammatory drug called baricitinib.

LEAVE A REPLY

Please enter your comment!
Please enter your name here